J0681 HCPCS Level II code: Injection, ceftobiprole medocaril sodium, 3 mg
J0681 is the HCPCS code for “Injection, ceftobiprole medocaril sodium, 3 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0681Injection, ceftobiprole medocaril sodium, 3 mg
Short description: Inj ceftobipole medocarl 3mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0681 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Oct 1, 2025
Where J0681 sits
- 1J codesDrugs administered other than orally
- 2Active code J0681Injection, ceftobiprole medocaril sodium, 3 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0681 mean?
J0681 is the HCPCS code for “Injection, ceftobiprole medocaril sodium, 3 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0681?
CMS lists J0681’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0681
All J codesJ0654Injection, liothyronine, 1 mcgJ0665Injection, bupivicaine, not otherwise specified, 0.5 mgJ0666Injection, bupivacaine liposome, 1 mgJ0668Instillation, bupivacaine and meloxicam, 1 mg/0.03 mgJ0670Injection, mepivacaine hydrochloride, per 10 mlJ0675Injection, carboprost tromethamine, 0.1 mgJ0687Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mgJ0688Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mgJ0689Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mgJ0690Injection, cefazolin sodium, 500 mgJ0691Injection, lefamulin, 1 mgJ0692Injection, cefepime hydrochloride, 500 mg